期刊文献+

丙型肝炎防治指南2015年更新版解读 被引量:5

Interpretation of guidelines on prevention and treatment of hepatitis C:2015 update
原文传递
导出
摘要 2015年中华医学会肝病学分会和感染病学分会组织国内专家对丙型肝炎防治指南进行了修订,新版指南从流行病学、实验室检测、抗病毒治疗目标及药物推荐、疗效评估、特殊人群抗病毒治疗等方面进行了更新和阐述,文章对新指南中重要的更新内容及要点进行解读,以供临床医生在实际工作中参考和应用。 Chinese Medical Association of liver diseases and infectious disease organized experts from china to revise the guidelines on prevention and treatment of hepatitis C in 2015. The new edition of guidelines is updated and elaborated from the aspects of epidemiology, laboratory testing, antiviral therapy, drug recommendation, efficacy evaluation, and antiviral treatment to special populations. This article will interpret the important content and key points of the new guidelines, for clinical reference and application.
作者 赵宁 李智伟
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2016年第3期192-194,共3页 Chinese Journal of Practical Internal Medicine
关键词 肝炎 丙型 指南 防治 hepatitis C guidelines prevention and treatment
  • 相关文献

参考文献3

二级参考文献28

  • 1Mohammad Irshad,Dhananjay Singh Mankotia,Khushboo Irshad.An insight into the diagnosis and pathogenesis of hepatitis C virus infection[J].World Journal of Gastroenterology,2013,19(44):7896-7909. 被引量:56
  • 2丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 3European Association for Study of Liver.EASL Clinical Practice Guidelines:management of hepatitis C virus infection[J].J Hepatol,2014,60:392-420.
  • 4Chevaliez S,Bouvier-Alias M,Brillet Rj et al.Hepatitis C virus(HCV)genotype I subtype identification in new HCV drug development and future clinical practice[J].PloS One,2009,4(12):e8209.
  • 5Lawitz E,Mangia A,Wyles D,et al.Sofosbuvir for previously untreated chronic hepatitis C infection[J].N EnglJ Med,2013,368:1878-1887.
  • 6Jacobson I,Dore GJ,Foster GR, et al.Simeprevir(TMC435)with peginterferon/ribavirin for chronic HCV genotype-1 infection in treatment-naive patients:results from QUEST-1,a Phase III trial[J].J Hepatol,2013,58(Suppl.1):SS74-S574.
  • 7Lalezari JP,Nelson DR,Hyland RH,et al.Once daily sofosbuvir plus ribavirin for 12 and 24 weeks in treatment-naive patients with HCV infection:the QUANTUM study[J].J Hepatol,2013,58(Suppl.1):S346-S346.
  • 8Ruane PJj Ain D,RiadJj et al.Sofosbuvir plus ribavirin in the treatment of chronic HCV genotype 4 infection in patients of Egyptian ancestry[J].Hepatology,2013,58(Suppl 1):736A.
  • 9Jacobson I,Ghalib RH,Rodriguez-Torres M,et al.SVR results of a once-daily regimen of simeprevir(TMC435)plus sofosbuvir(GS-7977)with or without ribavirin in cirrhotic and non-cirrhotic HCV genotype I treatment-naive and prior null responder patients:the COSMOS study[J].Hepatology,2013,58(Suppl.l):1379A.
  • 10Sulkowski MS,Gardiner DF,Rodriguez-Torres M,et al.Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection[J].N EnglJ Med,2014,370:211-221.

共引文献360

同被引文献31

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部